116 related articles for article (PubMed ID: 9699181)
1. Hormonal modulation of Ishikawa cells during three-dimensional growth in vitro.
Pinelli DM; Drake J; Williams MC; Cavanagh D; Becker JL
J Soc Gynecol Investig; 1998; 5(4):217-23. PubMed ID: 9699181
[TBL] [Abstract][Full Text] [Related]
2. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
3. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
Lau KM; LaSpina M; Long J; Ho SM
Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
[TBL] [Abstract][Full Text] [Related]
4. Estrogen activates migration potential of endometrial cancer cells through basement membrane.
Fujimoto J; Hori M; Ichigo S; Morishita S; Tamaya T
Tumour Biol; 1996; 17(1):48-57. PubMed ID: 7501972
[TBL] [Abstract][Full Text] [Related]
5. [Regulation of claudin-4 gene expression in endometrial adenocarcinoma Ishikawa cell line by progesterone].
Jin Y; Feng CP; Wang YN; Lin H; Li HJ; Pan XY
Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):368-72. PubMed ID: 22883527
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the functional progesterone receptor in an endometrial adenocarcinoma cell line (Ishikawa): progesterone-induced expression of the alpha1 integrin.
Lessey BA; Ilesanmi AO; Castelbaum AJ; Yuan L; Somkuti SG; Chwalisz K; Satyaswaroop PG
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):31-9. PubMed ID: 9009235
[TBL] [Abstract][Full Text] [Related]
7. Altered claudin-4 expression in progesterone-treated endometrial adenocarcinoma cell line Ishikawa.
Xiao-Yu P; Yan J; Cui-Ping F; Ya-Nan W; Hua L; Hua-Jun L
Int J Gynecol Cancer; 2012 Nov; 22(9):1585-90. PubMed ID: 23095775
[TBL] [Abstract][Full Text] [Related]
8. The effects of estradiol and selective estrogen receptor modulators on gene expression and messenger RNA stability in immortalized sheep endometrial stromal cells and human endometrial adenocarcinoma cells.
Farnell YZ; Ing NH
J Steroid Biochem Mol Biol; 2003 Mar; 84(4):453-61. PubMed ID: 12732290
[TBL] [Abstract][Full Text] [Related]
9. Functions of estrogens and anti-estrogens in the rat endometrial adenocarcinoma cell lines RUCA-I and RUCA-II.
Schütze N; Kraft V; Deerberg F; Winking H; Meitinger D; Ebert K; Knuppen R; Vollmer G
Int J Cancer; 1992 Dec; 52(6):941-9. PubMed ID: 1459735
[TBL] [Abstract][Full Text] [Related]
10. [Separation and characterization of estrogen independent endometrial cancer cell line originated from Ishikawa strain].
Shirakawa T; Sakamoto H; Satoh K
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Feb; 48(2):139-46. PubMed ID: 8718550
[TBL] [Abstract][Full Text] [Related]
11. Target specificity of selective estrogen receptor modulators within human endometrial cancer cells.
Bramlett KS; Burris TP
J Steroid Biochem Mol Biol; 2003 Jul; 86(1):27-34. PubMed ID: 12943742
[TBL] [Abstract][Full Text] [Related]
12. Characterization of HCI-EC-23 a novel estrogen- and progesterone-responsive endometrial cancer cell line.
Rush CM; Blanchard Z; Polaski JT; Osborne KS; Osby K; Vahrenkamp JM; Yang CH; Lum DH; Hagan CR; Leslie KK; Pufall MA; Thiel KW; Gertz J
Sci Rep; 2022 Nov; 12(1):19731. PubMed ID: 36396974
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
Gong Y; Ballejo G; Murphy LC; Murphy LJ
Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100
[TBL] [Abstract][Full Text] [Related]
14. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
Kumar NS; Richer J; Owen G; Litman E; Horwitz KB; Leslie KK
Cancer Res; 1998 May; 58(9):1860-5. PubMed ID: 9581825
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Bhat KP; Pezzuto JM
Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
[TBL] [Abstract][Full Text] [Related]
17. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells.
Reddel RR; Alexander IE; Koga M; Shine J; Sutherland RL
Cancer Res; 1988 Aug; 48(15):4340-7. PubMed ID: 3390830
[TBL] [Abstract][Full Text] [Related]
18. [Regulation of Bub1 mRNA expression in endometrial carcinoma Ishikawa cells by estrogen and paclitaxel].
Chen YH; Li XP; Wang Y; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):686-90. PubMed ID: 21092550
[TBL] [Abstract][Full Text] [Related]
19. Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones.
Havrilesky LJ; McMahon CP; Lobenhofer EK; Whitaker R; Marks JR; Berchuck A
J Soc Gynecol Investig; 2001; 8(2):104-13. PubMed ID: 11336882
[TBL] [Abstract][Full Text] [Related]
20. Endometrial stromal sarcoma expression of estrogen receptors, progesterone receptors and estrogen-induced srp27 (24K) suggests hormone responsiveness.
Navarro D; Cabrera JJ; León L; Chirino R; Fernández L; López A; Rivero JF; Fernández P; Falcón O; Jiménez P
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):589-96. PubMed ID: 1562530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
